Stock Price
29.06
Daily Change
-0.50 -1.69%
Monthly
0.41%
Yearly
14.86%
Q1 Forecast
27.85

Galapagos reported EUR12.56M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
argenx SE USD 38.4M 1.28M Jun/2025
AstraZeneca USD 85M 17M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Incyte USD 30.75M 3.97M Dec/2025
Merck EUR 17M 11M Jun/2025
Sanofi EUR 114M 38M Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025